Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus

Exclusion Criteria

• •1. Known or suspected allergy to the investigational product or its excipients, or have a history of allergy to human immunoglobulin products or other therapeutic monoclonal immunoglobulins;
• •2. Suspect or diagnosed as tetanus;
• •3. Previously diagnosed as Immunoglobulin A (IgA) deficiency with anti-IgA antibodies
• •4. Prior vaccination history of ≥ 3 doses of tetanus toxoid or tetanus toxoid- containing vaccine;
• •5. Current alcohol abuse, drug abuse or drug addiction